Amundi Asset Management US’s Galmed Pharmaceuticals GLMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q4
Sell
-47
Closed -$115K 1599
2018
Q3
$115K Hold
47
﹤0.01% 1468
2018
Q2
$101K Hold
47
﹤0.01% 1465
2018
Q1
$47K Buy
47
+13
+38% +$13K ﹤0.01% 1490
2017
Q4
$57K Buy
+34
New +$57K ﹤0.01% 1476